Penalized for “On-Label” Marketing? In Wake of Amarin, Pacira Files First Amendment Complaint Against FDA Read more
Genzyme Corp. Pays $32.5 Million To Resolve Criminal Charges Related to Med Device Promotion Read more
HHS Proposes Big Changes to “Common Rule” Policy for Protection of Human Research Subjects; Call for Comments Open Through December 7 Read more